Vital KSK Holdings (TSE:3151) Research & Development: 円0 Mil (TTM As of Mar. 2026)


TSE:3151 Vital KSK Holdings Inc TSE:3151
68 GF Score
Price 円1,520.00
GF Value 円1,322.65
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Vital KSK Holdings Research & Development?

Vital KSK Holdings TSE:3151 -0.85% 68 Research & Development is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:3151 with a GF Score™ of 68/100 and a GF Value™ of 円1,322.65 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Vital KSK Holdings's Research & Development for the three months ended in Mar. 2026 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.

Vital KSK Holdings  (TSE:3151) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Vital KSK Holdings Research & Development Related Terms

Vital KSK Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Vital KSK Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vital KSK Holdings Research & Development Chart

Vital KSK Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Vital KSK Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:3151
68GF Score
Vital KSK Holdings Inc TSE:3151
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vital KSK Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Vital KSK Holdings (TSE:3151) has a Research & Development of 円0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Vital KSK Holdings and its competitors.
Is Vital KSK Holdings' Research & Development too high?
Vital KSK Holdings' current Research & Development is 円0 Mil. Overall, Vital KSK Holdings has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' Research & Development compare to MCK and COR?
Vital KSK Holdings' Research & Development of 円0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Distribution company?
A good Research & Development depends on the Medical Distribution industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Vital KSK Holdings and its competitors. Vital KSK Holdings's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vital KSK Holdings (TSE:3151) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,322.65, compared to a current price of 円1,520.00 — trading 14.9% above its estimated fair value. The current Research & Development is 円0 Mil. Vital KSK Holdings' overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Vital KSK Holdings (TSE:3151), the current Research & Development is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vital KSK Holdings (TSE:3151) Overvalued in 2026?

Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued. The current stock price of 円1,520.00 is trading 14.9% above its estimated GF Value™ of 円1,322.65. GuruFocus considers Vital KSK Holdings to be Modestly Overvalued.

Key valuation signals for TSE:3151:

  • Research & Development: 円0 Mil
  • GF Value™: 円1,322.65 vs. price of 円1,520.00 (14.9% above fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the TSE:3151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vital KSK Holdings Business Description

Address 1-1-12 Tsurumaki, Setagaya-ku, JPN, 154-0016
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
68GF Score

Get the complete analysis for TSE:3151

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,520.00
Price
円1,322.65
GF Value